CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth
Eun Ju Lee, Ki Hoon Ahn, Soon Cheol Hong, Eun Hee Lee, Yong Park, Byung Soo Kim
Obstet Gynecol Sci. 2014;57(6):526-529.   Published online November 20, 2014
DOI: https://doi.org/10.5468/ogs.2014.57.6.526

Excel Download

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth
Obstetrics & Gynecology Science. 2014;57(6):526   Crossref logo
Link1 Link2 Link3

Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma
Therapeutic Advances in Hematology. 2021;12:204062072198957   Crossref logo
Link1 Link2 Link3

Expression of CD40 is a positive prognostic factor of diffuse large B-cell lymphoma treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)
OncoTargets and Therapy. 2016;3799   Crossref logo
Link1

Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphoma
Annals of Oncology. 2004;15(7):1086-1090   Crossref logo
Link1 Link2 Link3

Successful Treatment of Diffuse Large B-Cell Non-Hodgkin Lymphoma with Modified CHOP (Cyclophosphamide/Doxorubicin/Vincristine/ Prednisone) Chemotherapy and Rituximab in a Patient with Nijmegen Syndrome
Clinical Lymphoma and Myeloma. 2007;7(9):590-593   Crossref logo
Link1 Link2

Erratum: Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma
Cancer. 2011;118(13):3446-3446   Crossref logo
Link1 Link2

Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma
Cancer. 2011;117(15):3530-3530   Crossref logo
Link1 Link2

Reply to activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma
Cancer. 2011;117(15):3531-3531   Crossref logo
Link1 Link2

Prognostic significance ofMYC,BCL2, andBCL6rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab
Cancer. 2011;118(17):4173-4183   Crossref logo
Link1 Link2

Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma
Cancer. 2005;103(8):1644-1651   Crossref logo
Link1 Link2